Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 19.5 | 0.6 | 0.1 | 0.0 |
| Revenue growth | 2952.4% | 678.0% | -310.3% | |
| Cost of goods sold | 17.3 | 0.4 | 0.1 | -6.7 |
| Gross profit | 2.2 | 0.2 | 0.0 | 6.7 |
| Gross margin | 11.4% | 32.3% | -11.0% | -17166.7% |
| Selling, general and administrative | 82.7 | 41.5 | 6.8 | 3.4 |
| Research and development | 14.1 | 3.4 | 1.1 | |
| EBITA | -89.5 | -44.7 | -7.9 | -3.4 |
| EBITA margin | -459.6% | -7008.9% | -9661.0% | 8633.3% |
| Amortization of intangibles | 5.0 | | | |
| EBIT | -94.5 | -44.7 | -7.9 | -3.4 |
| EBIT margin | -485.4% | -7008.9% | -9661.0% | 8633.3% |
| Pre-tax income | -111.1 | -56.1 | -8.4 | -3.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -111.1 | -56.1 | -8.4 | -3.4 |
| Net margin | -570.4% | -8792.0% | -10254.9% | 8733.3% |
| |
| Diluted EPS | ($1.27) | ($1.06) | ($0.17) | ($0.35) |
| Shares outstanding (diluted) | 87.1 | 52.9 | 49.7 | 9.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|